Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
12.52
-0.46 (-3.51%)
At close: Apr 28, 2026, 4:00 PM EDT
12.54
+0.02 (0.20%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Contineum Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$19.00
Upside
+51.82%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Maintains $14 → $20 | Buy | Maintains | $14 → $20 | +59.81% | Mar 6, 2026 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $23 → $14 | Buy → Hold | Downgrades | $23 → $14 | +11.87% | Jan 8, 2026 |
| Baird | Baird | Buy Maintains $16 → $14 | Buy | Maintains | $16 → $14 | +11.87% | Nov 24, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $25 → $22 | Buy | Maintains | $25 → $22 | +75.79% | Nov 21, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $20 | Buy | Initiates | $20 | +59.81% | Sep 25, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $20 → $21 | Buy | Maintains | $20 → $21 | +67.80% | Aug 18, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $25 → $20 | Buy | Maintains | $25 → $20 | +59.81% | May 19, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $31 | Buy | Reiterates | $31 | +147.70% | May 15, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +83.78% | Mar 13, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $25 | Buy | Initiates | $25 | +99.76% | Mar 7, 2025 |
| Baird | Baird | Buy Maintains $32 → $16 | Buy | Maintains | $32 → $16 | +27.85% | Mar 7, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $31 | Buy | Reiterates | $31 | +147.70% | Jan 9, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $32 → $31 | Buy | Maintains | $32 → $31 | +147.70% | Nov 7, 2024 |
| Baird | Baird | Buy Initiates $32 | Buy | Initiates | $32 | +155.69% | Oct 22, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $30 → $32 | Buy | Maintains | $30 → $32 | +155.69% | Aug 14, 2024 |
| Stifel | Stifel | Strong Buy Initiates $29 | Strong Buy | Initiates | $29 | +131.72% | Apr 30, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.